Free Trial

Health Catalyst (HCAT) News Today

Health Catalyst logo
$5.49 -0.01 (-0.18%)
As of 01/17/2025 04:00 PM Eastern
Health Catalyst, Inc. stock logo
Health Catalyst, Inc. (NASDAQ:HCAT) Insider Sells $37,363.60 in Stock
Health Catalyst, Inc. (NASDAQ:HCAT - Get Free Report) insider Linda Llewelyn sold 6,442 shares of the stock in a transaction dated Wednesday, January 15th. The shares were sold at an average price of $5.80, for a total transaction of $37,363.60. Following the completion of the transaction, the insider now owns 92,260 shares of the company's stock, valued at $535,108. This represents a 6.53 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.
Stifel Nicolaus Remains a Hold on Health Catalyst (HCAT)
Evercore ISI Reaffirms Their Buy Rating on Health Catalyst (HCAT)
Health Catalyst, Inc. stock logo
Royal Bank of Canada Issues Pessimistic Forecast for Health Catalyst (NASDAQ:HCAT) Stock Price
Royal Bank of Canada dropped their price objective on shares of Health Catalyst from $9.00 to $7.00 and set a "sector perform" rating for the company in a research report on Wednesday.
Health Catalyst price target lowered to $7 from $9 at RBC Capital
Health Catalyst, Inc. stock logo
Health Catalyst, Inc. (NASDAQ:HCAT) Receives Average Recommendation of "Moderate Buy" from Analysts
Shares of Health Catalyst, Inc. (NASDAQ:HCAT - Get Free Report) have earned an average rating of "Moderate Buy" from the eleven research firms that are currently covering the company, Marketbeat.com reports. Two analysts have rated the stock with a hold recommendation and nine have issued a buy re
Health Catalyst (NASDAQ:HCAT) Upgraded to "Overweight" at KeyCorp
Health Catalyst, Inc. stock logo
Benjamin Landry Sells 2,500 Shares of Health Catalyst, Inc. (NASDAQ:HCAT) Stock
Health Catalyst, Inc. (NASDAQ:HCAT - Get Free Report) General Counsel Benjamin Landry sold 2,500 shares of the business's stock in a transaction dated Monday, January 6th. The stock was sold at an average price of $7.52, for a total value of $18,800.00. Following the sale, the general counsel now directly owns 72,250 shares of the company's stock, valued at $543,320. This represents a 3.34 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link.
Health Catalyst, Inc. stock logo
Insider Selling: Health Catalyst, Inc. (NASDAQ:HCAT) COO Sells 5,209 Shares of Stock
Health Catalyst, Inc. (NASDAQ:HCAT - Get Free Report) COO Daniel Lesueur sold 5,209 shares of the business's stock in a transaction that occurred on Monday, January 6th. The shares were sold at an average price of $7.51, for a total value of $39,119.59. Following the completion of the sale, the chief operating officer now directly owns 91,253 shares of the company's stock, valued at approximately $685,310.03. The trade was a 5.40 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link.
Health Catalyst price target lowered to $10 from $10.50 at Citi
Health Catalyst, Inc. stock logo
Citigroup Lowers Health Catalyst (NASDAQ:HCAT) Price Target to $10.00
Citigroup lowered their price target on shares of Health Catalyst from $10.50 to $10.00 and set a "buy" rating for the company in a report on Friday.
Health Catalyst, Inc. stock logo
Health Catalyst (NASDAQ:HCAT) Upgraded by KeyCorp to "Overweight" Rating
KeyCorp upgraded Health Catalyst from a "sector weight" rating to an "overweight" rating and set a $9.00 price target for the company in a research note on Wednesday.
Health Catalyst upgraded to Overweight from Sector Weight at KeyBanc
Health Catalyst, Inc. stock logo
Insider Selling: Health Catalyst, Inc. (NASDAQ:HCAT) Director Sells 4,500 Shares of Stock
Health Catalyst, Inc. (NASDAQ:HCAT - Get Free Report) Director Duncan Gallagher sold 4,500 shares of the firm's stock in a transaction dated Monday, December 30th. The stock was sold at an average price of $6.93, for a total value of $31,185.00. Following the completion of the transaction, the director now owns 69,938 shares in the company, valued at approximately $484,670.34. This trade represents a 6.05 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.
Health Catalyst, Inc. stock logo
Health Catalyst, Inc. (NASDAQ:HCAT) Given Average Rating of "Moderate Buy" by Brokerages
Health Catalyst, Inc. (NASDAQ:HCAT - Get Free Report) has received a consensus recommendation of "Moderate Buy" from the twelve analysts that are presently covering the company, Marketbeat.com reports. Three analysts have rated the stock with a hold recommendation and nine have issued a buy recomm
Health Catalyst, Inc. stock logo
Insider Selling: Health Catalyst, Inc. (NASDAQ:HCAT) Insider Sells 6,442 Shares of Stock
Health Catalyst, Inc. (NASDAQ:HCAT - Get Free Report) insider Linda Llewelyn sold 6,442 shares of the business's stock in a transaction dated Monday, December 16th. The stock was sold at an average price of $7.88, for a total transaction of $50,762.96. Following the sale, the insider now directly owns 98,702 shares in the company, valued at approximately $777,771.76. This represents a 6.13 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink.
Health Catalyst, Inc. stock logo
Health Catalyst, Inc. (NASDAQ:HCAT) Shares Bought by Point72 Asset Management L.P.
Point72 Asset Management L.P. lifted its position in shares of Health Catalyst, Inc. (NASDAQ:HCAT - Free Report) by 69.4% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 516,934 shares of the company's stock after buying an addit
Health Catalyst, Inc. stock logo
Jacobs Levy Equity Management Inc. Has $913,000 Position in Health Catalyst, Inc. (NASDAQ:HCAT)
Jacobs Levy Equity Management Inc. cut its holdings in Health Catalyst, Inc. (NASDAQ:HCAT - Free Report) by 86.0% in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 112,165 shares of the company's stock after selling 688,905 shares during the quarter. Jacobs Le
Health Catalyst, Inc. stock logo
Fred Alger Management LLC Invests $6.86 Million in Health Catalyst, Inc. (NASDAQ:HCAT)
Fred Alger Management LLC purchased a new stake in Health Catalyst, Inc. (NASDAQ:HCAT - Free Report) during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 842,509 shares of the company's stock, valued at appr
Health Catalyst, Inc. stock logo
Health Catalyst, Inc. (NASDAQ:HCAT) Shares Purchased by Connor Clark & Lunn Investment Management Ltd.
Connor Clark & Lunn Investment Management Ltd. raised its stake in Health Catalyst, Inc. (NASDAQ:HCAT - Free Report) by 118.0% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 131,532 shares of the company's s
Health Catalyst, Inc. stock logo
192,616 Shares in Health Catalyst, Inc. (NASDAQ:HCAT) Acquired by Millrace Asset Group Inc.
Millrace Asset Group Inc. purchased a new stake in Health Catalyst, Inc. (NASDAQ:HCAT - Free Report) during the third quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 192,616 shares of the company's stock, valued at ap
Health Catalyst, Inc. stock logo
Health Catalyst (NASDAQ:HCAT) Given "Overweight" Rating at Piper Sandler
Piper Sandler reaffirmed an "overweight" rating and set a $12.00 target price (up previously from $11.00) on shares of Health Catalyst in a research report on Tuesday.
Health Catalyst, Inc. stock logo
Health Catalyst, Inc. (NASDAQ:HCAT) Shares Sold by GSA Capital Partners LLP
GSA Capital Partners LLP lessened its position in shares of Health Catalyst, Inc. (NASDAQ:HCAT - Free Report) by 79.3% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 22,934 shares of the company's stock
Health Catalyst (HCAT) Receives a Buy from J.P. Morgan
Health Catalyst, Inc. stock logo
Health Catalyst, Inc. (NASDAQ:HCAT) Short Interest Update
Health Catalyst, Inc. (NASDAQ:HCAT - Get Free Report) was the recipient of a significant increase in short interest in the month of October. As of October 31st, there was short interest totalling 2,840,000 shares, an increase of 8.8% from the October 15th total of 2,610,000 shares. Based on an average daily volume of 473,600 shares, the days-to-cover ratio is currently 6.0 days.
Health Catalyst, Inc. stock logo
110,240 Shares in Health Catalyst, Inc. (NASDAQ:HCAT) Acquired by Janney Montgomery Scott LLC
Janney Montgomery Scott LLC bought a new position in Health Catalyst, Inc. (NASDAQ:HCAT - Free Report) in the third quarter, according to the company in its most recent disclosure with the SEC. The fund bought 110,240 shares of the company's stock, valued at approximately $897,000. Janney Montgomer
Health Catalyst price target raised to $9 from $7 at Stephens
Health Catalyst, Inc. stock logo
Stephens Issues Positive Forecast for Health Catalyst (NASDAQ:HCAT) Stock Price
Stephens boosted their target price on shares of Health Catalyst from $7.00 to $9.00 and gave the company an "equal weight" rating in a research report on Thursday.
Health Catalyst, Inc. stock logo
Baillie Gifford & Co. Reduces Position in Health Catalyst, Inc. (NASDAQ:HCAT)
Baillie Gifford & Co. trimmed its holdings in Health Catalyst, Inc. (NASDAQ:HCAT - Free Report) by 71.7% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 121,855 shares of the company's stock after selling 308,742 shares dur
Health Catalyst, Inc. stock logo
Health Catalyst (NASDAQ:HCAT) Announces Quarterly Earnings Results, Misses Expectations By $0.03 EPS
Health Catalyst (NASDAQ:HCAT - Get Free Report) posted its quarterly earnings results on Wednesday. The company reported $0.07 earnings per share for the quarter, missing the consensus estimate of $0.10 by ($0.03). Health Catalyst had a negative return on equity of 7.49% and a negative net margin of 26.20%. The business had revenue of $76.40 million during the quarter, compared to analysts' expectations of $76.27 million. During the same period in the prior year, the business posted ($0.22) earnings per share. The business's quarterly revenue was up 3.5% on a year-over-year basis.
Health Catalyst Reports Q3 Revenue Growth Amid Reduced Losses
Get Health Catalyst News Delivered to You Automatically

Sign up to receive the latest news and ratings for HCAT and its competitors with MarketBeat's FREE daily newsletter.

HCAT Media Mentions By Week

HCAT Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

HCAT
News Sentiment

0.09

0.46

Average
Medical
News Sentiment

HCAT News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

HCAT Articles
This Week

13

4

HCAT Articles
Average Week

Get Health Catalyst News Delivered to You Automatically

Sign up to receive the latest news and ratings for HCAT and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:HCAT) was last updated on 1/21/2025 by MarketBeat.com Staff
From Our Partners